This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Alere Analytics Launches Electronic Laboratory Reporting (ELR) Solution To Help Hospitals Automate Public Health Submissions And Satisfy Meaningful Use Requirements

Stocks in this article: ALR

Alere Analytics, an Alere subsidiary specializing in healthcare analytics and clinical decision support (CDS) technology, today announced the availability of its Electronic Laboratory Reporting (ELR) Solution to assist hospitals with submitting reportable lab results to State Departments of Health. Under Meaningful Use Stage 2, a new core objective requires that hospitals provide “ongoing successful submission of reportable lab results” to the State Departments of Public Health. As part of Alere Analytics’ Clinical Surveillance Solution, the ELR module can help eligible hospitals satisfy this requirement, while improving patient care quality and providing better coordination between lab personnel and clinicians.

“Our Company has been providing State Departments of Health with the necessary tools for statewide collection of reportable laboratory results for over a decade. Built on our extensive years of experience, our Electronic Laboratory Reporting (ELR) Solution was a natural product evolution of our core technology competencies,” said Mansoor Khan, Sc.D., Chief Executive Officer of Alere Analytics. “In addition to continuing to work with State Departments of Health, we are now pleased to directly offer hospital labs in all states our proven ELR technology as a low-cost, simple and effective way to satisfy Meaningful Use Stage 2, as well as provide a comprehensive solution to improve efficiency, patient safety, and outcomes while maximizing reimbursements.”

Delivered on the Alere Analytics platform using a cloud-based, SaaS environment, the ELR Solution captures all codes associated with diseases, conditions, lab tests and demographic data by leveraging industry messaging standards, such as HL7v2.X, and then delivers this information to the appropriate state authority. As a trusted technology partner, Alere Analytics is certified for Meaningful Use Stage 2 by the ONC-Authorized Testing and Certification Body for its Electronic Laboratory Reporting and Communication Portal. Alere Analytics’ ELR Solution, through which the State of Massachusetts has collected reportable lab results since 2004, is currently utilized by 98% of all hospitals in the state. The State of Iowa is also implementing the company’s ELR Solution to satisfy Meaningful Use requirements.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,090.33 +8.45 0.41%
NASDAQ 4,810.3630 +36.8910 0.77%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs